Drug comparisons
Ertugliflozin vs Vildagliptin
Ertugliflozin vs Vildagliptin: SGLT2 vs DPP-4 for type 2 diabetes. Compare mechanisms, benefits, risks, black box warning to find which is better.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when selecting add-on oral therapy after metformin for type 2 diabetes patients considering SGLT2 versus DPP-4 inhibitors.
Bottom line
Ertugliflozin and Vildagliptin both control blood sugar in type 2 diabetes but differ in extra benefits versus specific risks, so neither is universally superior.
All medication comparisons